Sator格罗夫控股

2023年5月24日

24.05.2023 / 29 CET(中央东部东京)/ c发行人单独负责这个声明的内容。MEDIQON集团:2022年年度报告——强大的经营业绩和持续成功收购——重命名和新董事提议在AGM着手下一章上周的增长,该公司公布2022年年度报告。与26日运营公司在年底,集团实现了67.1欧元的收入在2022年和2022年EBITDA 16.8欧元,增长64%和38%,分别比上年。虽然结果主要是由公司的成功的收购活动的平台组,同比2022年EBITDA增长也在+ 6.6%强。我们预计贪婪和有机增长在2023年继续。五年前,该公司开始了新的一页,当最初的“医疗哥伦布”集团的业务是出售,所得用于启动当前控股公司结构。随着时间的推移,我们进化非常,吸引优秀人才,企业主和一组质量世界一流股东加入我们的努力。这导致了我们的愿景和野心的快速扩张。展望未来,公司董事会提出重命名章节集团。我们选择这个名字来表达我们的信念,我们将开始一些新的和成功在未来公司的章。 To help us shape this next phase of our development, the company is seeking to add a talented and experienced investor and company builder to our supervisory board. Given his breadth of experience and talent, the company has asked Paul Buser to consider a nomination to join our supervisory board as a non-executive director. Paul is the co-founder and co-CEO of Sator Grove Holdings, one of our long-time shareholders. Paul has multiple decades of experience including as an investor, board member and executive. The company is pleased to propose his election at the upcoming AGM. “It’s an honor to be considered for the Supervisory Board at MEDIQON Group AG,” said Paul. “We have known and admired this team since its transformation from Medical Columbus and today serve as the company’s largest shareholder. The new ‘CHAPTERS GROUP’ is poised to accelerate its ambitions and seek to become the premier home for outstanding businesses and entrepreneurial talent across Europe. The structure that the management team has put in place should provide the opportunity to achieve this bold vision. I'm confident that top-tier talent will continue to be attracted to the CHAPTERS ecosystem – and the shareholder base consisting of long-term oriented world-class operators and investors will provide additional support to help us imagine and achieve the art of what’s possible. We stand ready to assist in any way to advance the mission of the company.” If approved, Paul would take over from Lars Ahns who offered his board seat to allow Paul to join. Lars has been a board member for nine years. During his leadership, the company transformed to its current form and his governance ensured an orderly and thoughtful reorganization of the group. Mathias Saggau, Chairman of the Supervisory Board, added, “I want to thank Lars for his great service over the last years. He has been a great supporter and advisor to our management team and we will miss his contributions. We are excited that Paul agreed to stand for election at the next AGM. The guidance and network that Paul and his team at Sator Grove have provided over the past years as shareholders have had a tremendous positive impact. We are looking forward to working together closely.” “It’s bittersweet leaving the business at this juncture given the tremendous progress we’ve made and the fulfilling nature of working alongside the team,” said Lars Ahns. “I will remain closely connected to the company as a shareholder and wish Paul and the company all the best in the coming years ahead.” Our shareholders will have the chance to vote on both the proposed name change and Paul Buser’s appointment at the upcoming AGM on June, 29th, 2023 This year’s AGM will take place in Hamburg and we also propose to move our legal seat to Hamburg as that’s where our management head office has been located since 2020. The invite to the event can be downloaded via the website of the company: Hauptversammlung - MEDIQON group AG (mediqon-group.de) After the AGM, we are holding an Investor Event in English. Details on the event will be published on our website shortly. Please sign up via ir@mediqon-group.de. 24.05.2023 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement. The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Archive at www.eqs-news.com